Literature DB >> 10988092

Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

D Gruson1, G Hilbert, F Vargas, R Valentino, C Bebear, A Allery, C Bebear, G Gbikpi-Benissan, J P Cardinaud.   

Abstract

To test the hypothesis that a new program of antibiotic strategy control can minimize the incidence of ventilator-associated pneumonia (VAP) caused by potentially antibiotic-resistant microorganisms, we performed a prospective before-after study in 3, 455 patients admitted to a single intensive care unit over a 4-yr period. Regarding the bacterial ecology and the increasing antimicrobial resistance in our medical intensive care unit (MICU), we decided to vary our choice of empiric and therapeutic antibiotic treatment, with a supervised rotation, and a restricted use of ceftazidime and ciprofloxacin, which were widely prescribed before this scheduled change. For all patients, VAP was diagnosed based on the results of quantitative culture of bronchoalveolar lavage specimens (>/= 10(4) cfu/ml). We studied 1,044 and 1,022 patients requiring more than 48 h of mechanical ventilation (MV), respectively, in the before-period (2 yr: 1995-1996) and the after-period (2 yr: 1997-1998). We observed a decrease from 231 consecutive episodes of VAP in the before-period to 161 episodes of VAP in the after-period (p < 0.01), particularly for VAP occurring before 7 d of MV. The total number of potentially antibiotic-resistant gram-negative bacilli responsible for VAP such as Pseudomonas aeruginosa, Burkholderia cepacia, Steno-trophomonas maltophilia, and Acinetobacter baumanii decreased from 140 to 79 isolated bacilli. The susceptibilities of these bacteria to the antibiotics regimen increased significantly, especially for P. aeruginosa and B. cepacia. The percentage of methicillin-sensitive Staphylococcus aureus increased significantly from 40% to 60% of S. aureus responsible for VAP. These results suggest that a new strategy of antibiotics use could be an efficient means to reduce the incidence of VAP caused by antibiotic-resistant bacteria. Nevertheless, further studies are needed to validate these data.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988092     DOI: 10.1164/ajrccm.162.3.9905050

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  44 in total

1.  Approaches to suspected ventilator-associated pneumonia: relying on our own bias.

Authors:  S Ewig; A Torres
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

2.  Nosocomial Pneumonia: More Than Just Ventilator-Associated.

Authors:  Joseph R. Lentino
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

3.  Linezolid in VAP by MRSA: a better choice?

Authors:  Malina Ioanas; Hartmut Lode
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

4.  Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals.

Authors:  Carl T Bergstrom; Monique Lo; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-12       Impact factor: 11.205

5.  Antimicrobial stewardship.

Authors:  Shira Doron; Lisa E Davidson
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

6.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

Review 7.  Management of antimicrobial use in the intensive care unit.

Authors:  Francisco Álvarez-Lerma; Santiago Grau
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

8.  Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward.

Authors:  Yoshio Takesue; Hiroki Ohge; Mitsuru Sakashita; Takeshi Sudo; Yoshiaki Murakami; Kenichiro Uemura; Taijiro Sueda
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

9.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 10.  Nursing home-associated pneumonia, hospital-acquired pneumonia and ventilator-associated pneumonia: the contribution of dental biofilms and periodontal inflammation.

Authors:  Krishnan Raghavendran; Joseph M Mylotte; Frank A Scannapieco
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.